“…In the recent GC-MS methods, solid phase extraction (SPE) and selected ion monitoring (SIM) were applied [4][5][6][7], for which the reported limits of quantification (LOQ) for fentanyl and sufentanil were as low as 0.0025 ng/mL. In the recently described LC-MS/MS methods, the analysis usually included one to four fentanyls [8][9][10][11][12][13][14][15][16]. Only one A method for simultaneous screening and quantification was developed for the fentanyls alfentanil, fentanyl, p-fluorofentanyl, cis-3-methylfentanyl, trans-3-methylfentanyl, alpha-methylfentanyl, norfentanyl, remifentanil, sufentanil, and the other opioid drugs 6-acetylmorphine, buprenorphine, codeine, dextropropoxyphene, ethylmorphine, heroin, methadone, morphine, naloxone, naltrexone, norbuprenorphine, normethadone, oxycodone, pentazocine, pethidine, and tramadol in post-mortem blood and urine samples by LC-MS/MS.…”